On August 31, 2023 Fate Therapeutics, Inc. (the "Company" or "Fate Therapeutics") (NASDAQ: FATE), a clinical-stage biopharmaceutical company dedicated to bringing a first-in-class pipeline of induced pluripotent stem cell (iPSC)-derived cellular immunotherapies to patients with cancer and autoimmune disorders, reported that the Company will participate in the following upcoming investor conferences (Press release, Fate Therapeutics, AUG 31, 2023, View Source [SID1234634798]):

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Citi’s 18th Annual BioPharma Conference on Thursday, September 7, 2023 in Boston, Massachusetts

Hosting 1×1 investor meetings only
Wells Fargo 2023 Healthcare Conference on Friday, September 8, 2023 at 9:30 AM ET in Boston, Massachusetts

Participating in a fireside chat and hosting 1×1 investor meetings
A live webcast, if recorded, of each presentation can be accessed under "Events & Presentations" in the Investors section of the Company’s website at www.fatetherapeutics.com. The archived webcast will be available on the Company’s website shortly after the event.